Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results